Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

500 Saginaw Drive
Redwood City, CA 94063
Phone: 650-595-2595

Atreca is a privately held biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. We are able to measure and analyze the structure of clinically relevant immune responses to identify the antibodies, T cell receptors, and targets that are key to successful treatment outcomes. Atreca's proprietary Immune Repertoire Capture technology profiles a patient's immune response at the single-cell level at very high throughput essentially without bias or error, enabling the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen.

Key Contact
Tito A Serafini, PhD
President & CEO
Funding Events

08/17/17 $35,000,000 Series B Cormorant Asset Management
Wellington Management Company
09/13/18 $125,000,000 Series C Aisling Capital
Boxer Capital
Cormorant Asset Management
EcoR1 Capital
Redmile Group
Samsara BioCapital
Tavistock Group
Tekla Capital Management
Wellington Management Company

Featured Reading